Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: phase III randomised placebo controlled trial (MIR)

Kessler, DS; MacNeill, SJ; Tallon, D; Lewis, G; Peters, TJ; Hollingworth, W; Round, J; ... Wiles, NJ; + view all Kessler, DS; MacNeill, SJ; Tallon, D; Lewis, G; Peters, TJ; Hollingworth, W; Round, J; Burns, A; Chew-Graham, CA; Anderson, IM; Shepherd, T; Campbell, J; Dickens, CM; Carter, M; Jenkinson, C; Macleod, U; Gibson, H; Davies, S; Wiles, NJ; - view fewer (2018) Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: phase III randomised placebo controlled trial (MIR). BMJ , 363 , Article k4218. 10.1136/bmj.k4218 . Green open access

https://ift.tt/2RNPbAA